Dysregulation of alternative splicing in prostate cancer is linked to transcriptional programs activated by AR, ERG, FOXA1, and MYC. Here, we show that FOXA1 functions as the primary orchestrator of alternative splicing dysregulation across 500 primary and metastatic prostate cancer transcriptomes. We demonstrate that FOXA1 binds to the regulatory regions of splicing-related genes, including HNRNPK and SRSF1. By controlling trans -acting factor expression, FOXA1 exploits an "exon definition"mechanism calibrating alter-native splicing toward dominant isoform production. This regulation especially impacts splicing factors themselves and leads to a reduction of nonsense-mediated decay (NMD)-targeted isoforms. Inclusion of the NMD-determinant FLNA exon 30 by FOXA1-controlled oncogene SRSF1 promotes cell growth in vitro and predicts disease recurrence. Overall, we report a role for FOXA1 in rewiring the alternative splicing land-scape in prostate cancer through a cascade of events from chromatin access, to splicing factor regulation, and, finally, to alternative splicing of exons influencing patient survival.

FOXA1 regulates alternative splicing in prostate cancer

Peirone, Serena;Rissone, Alberto;Caizzi, Livia;Gaudino, Federica;Anselmi, Francesca;Guarrera, Simonetta;Oliviero, Salvatore;Cereda, Matteo
Co-last
2022-01-01

Abstract

Dysregulation of alternative splicing in prostate cancer is linked to transcriptional programs activated by AR, ERG, FOXA1, and MYC. Here, we show that FOXA1 functions as the primary orchestrator of alternative splicing dysregulation across 500 primary and metastatic prostate cancer transcriptomes. We demonstrate that FOXA1 binds to the regulatory regions of splicing-related genes, including HNRNPK and SRSF1. By controlling trans -acting factor expression, FOXA1 exploits an "exon definition"mechanism calibrating alter-native splicing toward dominant isoform production. This regulation especially impacts splicing factors themselves and leads to a reduction of nonsense-mediated decay (NMD)-targeted isoforms. Inclusion of the NMD-determinant FLNA exon 30 by FOXA1-controlled oncogene SRSF1 promotes cell growth in vitro and predicts disease recurrence. Overall, we report a role for FOXA1 in rewiring the alternative splicing land-scape in prostate cancer through a cascade of events from chromatin access, to splicing factor regulation, and, finally, to alternative splicing of exons influencing patient survival.
2022
40
13
1
25
CP: Cancer; CP: Molecular biology; FLNA; FOXA1; HNRNPK; SRSF1; alternative splicing; biomarkers; nonsense-mediated decay; poison exons; prostate cancer; splicing factors
Del Giudice, Marco; Foster, John G; Peirone, Serena; Rissone, Alberto; Caizzi, Livia; Gaudino, Federica; Parlato, Caterina; Anselmi, Francesca; Arkell...espandi
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S2211124722012414-main.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 2.58 MB
Formato Adobe PDF
2.58 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1882057
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 12
social impact